Skip to main content

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer

Include preview-only content
  1. Article

    Open Access

    Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma

    TFE3-rearranged renal cell carcinoma (TFE3-rRCC) is a rare but highly heterogeneous renal cell carcinoma (RCC) entity, of which the clinical treatment landscape is largely undefined. This study aims to evaluate a...

    Junjie Zhao, Yanfeng Tang, Xu Hu, **aoxue Yin, Yuntian Chen, Junru Chen in Molecular Cancer (2024)

  2. Article

    Open Access

    CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma

    Cell division cycle 6 (CDC6) has been proven to be associated with the initiation and progression of human multiple tumors. However, it’s role in glioma, which is ranked as one of the common primary malignant ...

    Feng Wang, Fen Zhao, Li Zhang, Lai **ong, Qing Mao, Yanhui Liu in Molecular Cancer (2022)

  3. Article

    Open Access

    Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma

    In clinical practice, the detection of biomarkers is mostly based on primary tumors for its convenience in acquisition. However, immune checkpoints may express differently between primary and metastatic tumor....

    **ngming Zhang, **aoxue Yin, Haoran Zhang, Guangxi Sun, Yao**g Yang in BMC Cancer (2019)

  4. Article

    Open Access

    Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma

    Due to the significant heterogeneity of renal cell carcinoma (RCC), immune checkpoints may express differently between primary and metastatic tumor. We aimed to evaluate the differential expression of TIM-3 be...

    **ngming Zhang, **aoxue Yin, Haoran Zhang, Guangxi Sun, Yao**g Yang in BMC Cancer (2019)

  5. Article

    Open Access

    Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer

    Emerging studies show that long noncoding RNAs (lncRNAs) play important roles in carcinogenesis and cancer progression. The lncRNA ZEB1 antisense 1 (ZEB1-AS1) derives from the promoter region of ZEB1 and we st...

    Wen**g Su, Miao Xu, Xueqin Chen, Ni Chen, **g Gong, Ling Nie, Ling Li in Molecular Cancer (2017)

  6. Article

    Open Access

    Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma

    An increased incidence of venous thromboembolism (VTE) is associated with anti-vascular endothelial growth factor (VEGF) treatment in cancer. However, the mechanism underlying this effect remains elusive. In t...

    Ni Chen, Mei** Ren, Rong Li, **n Deng, Yongjie Li, Kai Yan in Molecular Cancer (2015)

  7. Article

    Open Access

    Presence of intratumoral platelets is associated with tumor vessel structure and metastasis

    Platelets play a fundamental role in maintaining hemostasis and have been shown to participate in hematogenous dissemination of tumor cells. Abundant platelets were detected in the tumor microenvironment outsi...

    Rong Li, Mei** Ren, Ni Chen, Mao Luo, **n Deng, Jiyi **a, Guang Yu in BMC Cancer (2014)